News!

This is the latest in the Cushing's Help family of websites.  Be sure to check them all out! It all started with  www.cushings-help.com in July of 2000...
Read more...

Cushing's Info

It's About Time There Was Some Support!

 

Total Members : 1169
Latest Member : pbjfjt65477
This Week : 22 Registers
This Month : 52 Registers

Members Online

None

Member Login






Login reminder Forgot login?
Register Register

Follow Us on Pinterest

<<  May 2013  >>
 Su  Mo  Tu  We  Th  Fr  Sa 
     1  2  3  4
  5  6  7  8  91011
12131415161718
19202122232425
262728293031 
05
Jun
2011
NIH Pituitary Clinical Trials Updated 6/5/2011
smaller text tool iconmedium text tool iconlarger text tool icon

Rank

 Status Study
1 Recruiting Prevalence of Pituitary Incidentaloma in Relatives of Patients With Pituitary Adenoma
Condition: Pituitary Tumor
Intervention:
2 Not yet recruiting Evaluate the Efficacy and Safety of Pasireotide LAR on the Treatment of Patients With Clinically Non-Functioning Pituitary Adenoma
Condition: Nonfunctioning Pituitary Tumor
Intervention: Drug: Pasireotide LAR
3 Recruiting Pituitary Tumor Surveillance: Pathogenic Correlation
Condition: Pituitary Tumor
Intervention:
4 Unknown † Measurement of Pituitary Volume and Hormonal Changes in Patients With Post-Traumatic Stress Disorder
Condition: Posttraumatic Stress Disorder
Interventions: Procedure: MRI of the pituitary;   Procedure: DEX/CRH test
5 Recruiting Temozolomide in Treating Patients With Invasive Pituitary Tumors
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: temozolomide;   Genetic: DNA methylation analysis;   Genetic: microarray analysis;   Genetic: protein expression analysis;   Genetic: proteomic profiling;   Other: laboratory biomarker analysis
6 Recruiting An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
Conditions: Abnormalities;   Craniopharyngioma;   Cushing's Syndrome;   Endocrine Disease;   Pituitary Neoplasm
Intervention:
7 Recruiting Study of Thyrotropin-Releasing Hormone in Normal Volunteers and in Patients With Thyroid or Pituitary Abnormalities
Conditions: Healthy;   Pituitary Disease;   Thyroid Disease
Intervention: Drug: TRH (Thyrotropin Releasing Hormone)
8 Recruiting The Diagnostic Accuracy of the Glucagon Stimulation Test for Evaluation of Adult Growth Hormone Deficiency and the Hypothalamic-Pituitary-Adrenal Axis
Conditions: Adult Growth Hormone Deficiency;   Hypothalamic-pituitary Disorders
Interventions: Procedure: Glucagon stimulation test and insulin tolerance test;   Procedure: glucagon stimulation test and insulin tolerance test
9 Recruiting Proton Radiation Therapy for Pituitary Adenoma
Condition: Pituitary Adenoma
Intervention: Radiation: Proton Radiation Therapy
10 Recruiting Ante-hypophyseal Dysfunctions in Children Following Moderate to Severe Traumatic Brain Injuries
Condition: Moderate to Severe Traumatic Brain Injury
Intervention: Other: Biological and behavioral explorations
11 Recruiting Targeted Therapy With Lapatinib in Patients With Recurrent Pituitary Tumors Resistant to Standard Therapy
Conditions: Adenoma;   Prolactinoma
Intervention: Drug: Lapatinib
12 Not yet recruiting To Describe the Effect of rhLH Supplementation in Women With Hyporesponse to rhFSH After Pituitary Downregulation
Condition: Infertility
Intervention: Drug: Luveris
13 Recruiting The Effect of Monoclonal Vascular Endothelial Growth Factor (VEGF) Antibody (Bevacizumab) on Pituitary Function
Conditions: Colorectal Cancer;   Lung Cancer;   Breast Cancer;   Glioblastoma
Intervention:
14 Recruiting Anterior Pituitary Hormone Replacement in Traumatic Brain Injury
Conditions: Growth Hormone Deficiency;   Traumatic Brain Injury
Interventions: Drug: Human Growth Hormone;   Drug: Placebo
15 Recruiting Rosiglitazone in Treating Patients With Newly Diagnosed ACTH-Secreting Pituitary Tumor (Cushing Disease)
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: rosiglitazone maleate;   Other: laboratory biomarker analysis
16 Recruiting Evaluation of Patients With Thyroid Disorders
Conditions: Hyperthyroidism;   Hypothyroidism;   Pituitary Neoplasm
Intervention:
17 Recruiting Effects of Growth Hormone Administration on Cardiovascular Risk in Cured Acromegalics With Growth Hormone Deficiency
Conditions: Acromegaly;   Growth Hormone Deficiency;   Pituitary Disease
Interventions: Drug: Somatropin;   Drug: Placebo
18 Unknown † Pituitary Functions After Traumatic Brain Injury (TBI) and/or Subarachnoid Hemorrhage (SAH)
Conditions: Traumatic Brain Injury;   Subarachnoid Hemorrhage;   Hypopituitarism
Intervention:
19 Recruiting The Treatment and Natural History of Acromegaly
Conditions: Acromegaly;   Pituitary Neoplasm
Intervention:
20 Recruiting Barrow Nasal Inventory Survey
Condition: Pituitary Tumors
Intervention:

 

Rank Status Study
21 Recruiting VRS-317 in Adult Subjects With Growth Hormone Deficiency
Condition: Growth Hormone Deficiency
Intervention: Drug: VRS-317
22 Recruiting Age-related Variability of the Efficacy and Tolerability of Alternative Pituitary Suppression Regimens in ART
Condition: Infertility
Intervention: Drug: hFSH（Fostimon）
23 Unknown † Does Topical Steroid Treatment Impair the Adrenal Function?
Conditions: Hypothalamus-Pituitary-Adrenal Axis Assessement;   Topical Steroid Therapy in Chronic Skin Diseases
Intervention:
24 Recruiting Assessment of Pituitary Adenylate Cyclase Activating Polypeptide-Brain Derived Neurotrophic Factor (PACAP-BDNF) Signaling System Involvement in Etiology and Treatment of Major Depression
Condition: Major Depression
Intervention: Drug: SSRI; SNRI; TCA
25 Recruiting Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin
Conditions: Pancreatic Neoplasm;   Pituitary Neoplasm;   Nelson Syndrome;   Ectopic ACTH Syndrome
Intervention: Drug: Pasireotide LAR
26 Unknown † Pituitary Derived-Intermedin is an Estrogen-Modulated Factor for Reducing Blood Pressure
Conditions: Menopause;   Hypertension
Intervention: Behavioral: intermedin
27 Recruiting Adult Growth Hormone Deficiency and Cardiovascular Risk
Condition: Growth Hormone Deficiency
Interventions: Procedure: Blood draws;   Drug: Growth hormone releasing hormone (GHRH) and arginine;   Procedure: Carotid ultrasound;   Procedure: MRI;   Procedure: Endothelial cell biopsy
28 Recruiting Quetiapine Prolong, Escitalopram and Hypothalamic-pituitary-adrenocortical (HPA) Axis Activity in Depressed Patients
Condition: Major Depression
Interventions: Drug: quetiapine;   Drug: escitalopram
29 Recruiting Stress, Hypothalamic-Pituitary-Adrenal (HPA) Dysfunction, and Relapse in Alcoholism
Condition: Alcohol Dependence
Intervention:
30 Recruiting A Comparative Study of Global 12 Lead Electroencephalogram to Frontal SedlineTM Electroencephalogram
Conditions: Craniotomy;   Transphenoidal Pituitary Resection
Intervention:
31 Recruiting Genetics of Endocrine Tumours
Condition: Acromegaly
Intervention:
32 Unknown † Testosterone Gel Applied to Women With Pituitary Gland Problems
Condition: Panhypopituitarism
Intervention: Drug: Transdermal Testosterone gel
33 Recruiting Lanreotide as Primary Treatment for Acromegalic Patients With Pituitary Gland Macroadenoma
Condition: Acromegaly
Intervention: Drug: Lanreotide autogel 120 mg
34 Recruiting Detection and Treatment of Endocrine Abnormalities in Childhood Cancer Survivors
Conditions: Hypopituitarism;   Hypogonadism;   Thyroid Dysfunction;   Bone Diseases, Metabolic
Intervention:
35 Recruiting A Study Examining the Peri- and Post-operative Dynamics of the Growth Hormone (GH) - IGF-1 Axis in Subjects With Acromegaly During the First Year After Surgical Resection
Condition: Acromegaly
Intervention: Other: OGTT
36 Recruiting Clinical and Biological Characteristics of Psychotic Depression
Conditions: Depression;   Psychotic Disorders;   Depressive Disorder, Major
Intervention:
37 Recruiting Efficacy and Safety of Pasireotide Long Acting Release (LAR) Versus Octreotide LAR or Lanreotide Autogel (ATG) in Patients With Inadequately Controlled Acromegaly
Condition: Acromegaly
Interventions: Drug: Pasireotide (SOM230);   Drug: octreotide LAR 30mg or lanreotide ATG 120mg
38 Recruiting Single Dose FSH-GEX™ in Healthy Volunteers
Condition: Female Infertility
Interventions: Drug: FSH-GEX™;   Drug: Comparator 1;   Drug: Comparator 2;   Drug: Placebo
39 Recruiting Endocrine and Psychological Evaluation of Adopted Children
Condition: Psychosocial Adjustment
Intervention:
40 Recruiting Safety and Efficacy of LCI699 in Cushing's Disease Patients
Condition: Cushing Disease
Intervention: Drug: LCI699
Back to Top
< Prev   Next >
Last Updated ( Sunday, 05 June 2011 18:36 )
 
You Might Also Like...

Add comment


Security code
Refresh
" I am so thankful for this site and the internet as my diagnosis came through the research I did on myself. It is sad that others need attention through sickness, I feel sympathy for that. I am so glad for all of the positives out here and the help this site can give to those that truly need it. Thank you Mary for saving lives! "
Mom first

Read These?

Pituitary Hormones

The pituitary gland is a small gland, located below the brain and connected to the hypothalamus. The pituitary gland regulates the secretions of hormones in the body, and hormones impact metabolism, [ ... ]


Read more...
Pasireotide in Cushing's Disease

N Engl J Med 2012; 366:2134-2135 May 31, 2012   To the Editor: In their study, Colao et al. (March 8 issue)1 examined the clinical efficacy and safety of two different doses of subcutaneous  [ ... ]


Read more...
Other Articles

Related

Facebook

Twitter
Disclaimer

Did you find this information useful?
All site features are available free of charge thanks to the kind support of our donors,
many of them Cushing's patients, friends and family.
No forms of advertising are used on Cushie.info.
All donations are gratefully accepted!

Site Design and Maintenance: Mary O'Connor, Founder and Webmaster

2012 Cushings Help. All rights reserved.
Joomla 1.5 Templates by Joomlashack